The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force
Open accessAbstract
Importance: Effective prevention strategies for HIV infection are an important public health priority. Preexposure prophylaxis (PrEP) involves use of antiretroviral therapy (ART) daily or before and after sex to decrease risk of acquiring HIV infection. Objective: To synthesize the evidence on the benefits and harms of PrEP, instruments for predicting incident HIV infection, and PrEP adherence to inform the US Preventive Services Task Force. Data Sources: Ovid MEDLINE, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, and EMBASE through June 2018, with surveillance through January 2019. Study Selection: English-language placebo-controlled randomized clinical trials of oral PrEP with tenofovir disoproxil fumarate/emtricitabine or tenofovir disoproxil fumarate monotherapy; studies on the diagnostic accuracy of instruments for predicting incident HIV infection; and studies on PrEP adherence. Data Extraction and Synthesis: Dual review of titles and abstracts, full-text articles, study quality, and data abstraction. Data were pooled using the Dersimonian and Laird random-effects model for effects of PrEP on HIV infection, mortality, and harms. Main Outcomes and Measures: HIV acquisition, mortality, and harms; adherence to PrEP; and diagnostic test accuracy and discrimination. Results: Fourteen RCTs (N = 18 837), 8 observational studies (N = 3884), and 7 studies of diagnostic accuracy (N = 32 279) were included. PrEP was associated with decreased risk of HIV infection vs placebo or no PrEP after 4 months to 4 years (11 trials; relative risk [RR], 0.46 [95% CI, 0.33-0.66]; I2 = 67%; absolute risk reduction [ARD], -2.0% [95% CI, -2.8% to -1.2%]). Greater adherence was associated with greater efficacy (RR with adherence ≥70%, 0.27 [95% CI, 0.19-0.39]; I2 = 0%) in 6 trials. PrEP was associated with an increased risk of renal adverse events (12 trials; RR, 1.43 [95% CI, 1.18-1.75]; I2 = 0%; ARD, 0.56% [95% CI, 0.09%-1.04%]) and gastrointestinal adverse events (12 trials; RR, 1.63 [95% CI, 1.26-2.11]; I2 = 43%; ARD, 1.95% [95% CI, 0.48%-3.43%]); most adverse events were mild and reversible. Instruments for predicting incident HIV infection had moderate discrimination (area under the receiver operating characteristic curve, 0.49-0.72) and require further validation. Adherence to PrEP in the United States in men who have sex with men varied widely (22%-90%). Conclusions and Relevance: In adults at increased risk of HIV infection, PrEP with oral tenofovir disoproxil fumarate monotherapy or tenofovir disoproxil fumarate/emtricitabine was associated with decreased risk of acquiring HIV infection compared with placebo or no PrEP, although effectiveness decreased with suboptimal adherence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K., Clarke, A., Reeves, I., Schembri, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00056-2 · Cited by 1,878
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C., Le Gall, J.-M., Cua, E., Pasquet, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506273 · Cited by 1,633
Preexposure Prophylaxis for HIV Infection among African Women
Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,603
Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61127-7 · Cited by 1,463
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., Hosek, S., Mosquera, C., Casapia, M., Montoya, O., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70847-3 · Cited by 1,208
Anderson, P. L., Glidden, D. V., Liu, A., Buchbinder, S., Lama, J. R., Guanira, J. V., McMahan, V., Bushman, L. R., Casapía, M., Montoya-Herrera, O., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004006 · Cited by 1,020
Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
Fonner, V. A., Dalglish, S. L., Kennedy, C. E., Baggaley, R., O’Reilly, K. R., Koechlin, F. M., Rodolph, M., Hodges-Mameletzis, I., & Grant, R. M. (2016) · AIDS · doi:10.1097/qad.0000000000001145 · Cited by 993
Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4683 · Cited by 602
Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change
Cornell, J. E., Mulrow, C. D., Localio, R., Stack, C. B., Meibohm, A. R., Guallar, E., & Goodman, S. N. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2886 · Cited by 453
Traeger, M. W., Schroeder, S. E., Wright, E. J., Hellard, M. E., Cornelisse, V. J., Doyle, J. S., & Stoové, M. A. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy182 · Cited by 447
Donnell, D., Baeten, J. M., Bumpus, N. N., Brantley, J., Bangsberg, D. R., Haberer, J. E., Mujugira, A., Mugo, N., Ndase, P., Hendrix, C., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000172 · Cited by 358
Cottrell, M. L., Yang, K. H., Prince, H. M. A., Sykes, C., White, N., Malone, S., Dellon, E. S., Madanick, R. D., Shaheen, N. J., Hudgens, M. G., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw077 · Cited by 300
Smith, D. K., Pals, S. L., Herbst, J. H., Shinde, S., & Carey, J. W. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318256b2f6 · Cited by 278
Peterson, L., Taylor, D., Roddy, R., Belai, G., Phillips, P., Nanda, K., Grant, R., Clarke, E. E. K., Doh, A. S., Ridzon, R., et al. (2007) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0020027 · Cited by 277
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial
Deutsch, M. B., Glidden, D. V., Sevelius, J., Keatley, J., McMahan, V., Guanira, J., Kallas, E. G., Chariyalertsak, S., & Grant, R. M. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00206-4 · Cited by 268
An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM
Hosek, S. G., Rudy, B., Landovitz, R., Kapogiannis, B., Siberry, G., Rutledge, B., Liu, N., Brothers, J., Mulligan, K., Zimet, G., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001179 · Cited by 267
Haberer, J. E., Baeten, J. M., Campbell, J., Wangisi, J., Katabira, E., Ronald, A., Tumwesigye, E., Psaros, C., Safren, S. A., Ware, N. C., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001511 · Cited by 224
Hosek, S. G., Landovitz, R. J., Kapogiannis, B., Siberry, G. K., Rudy, B., Rutledge, B., Liu, N., Harris, D. R., Mulligan, K., Zimet, G., et al. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.2007 · Cited by 220
Chan, P. A., Mena, L., Patel, R., Oldenburg, C. E., Beauchamps, L., Perez‐Brumer, A. G., Parker, S., Mayer, K. H., Mimiaga, M. J., & Nunn, A. (2016) · Journal of the International AIDS Society · doi:10.7448/ias.19.1.20903 · Cited by 218
Chou, R., Aronson, N., Atkins, D., Ismaila, A. S., Santaguida, P., Smith, D. H., Whitlock, E., Wilt, T. J., & Moher, D. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.06.007 · Cited by 184
Self-citationPrediction of HIV Acquisition Among Men Who Have Sex With Men
Menza, T. W., Hughes, J. P., Celum, C. L., & Golden, M. R. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181a9cc41 · Cited by 177
Hosek, S. G., Siberry, G., Bell, M., Lally, M., Kapogiannis, B., Green, K., Isabel Fernandez, M., Rutledge, B., Martinez, J., Garofalo, R., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182801081 · Cited by 173
Grohskopf, L. A., Chillag, K. L., Gvetadze, R., Liu, A. Y., Thompson, M., Mayer, K. H., Collins, B. M., Pathak, S. R., O'Hara, B., Ackers, M. L., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31828ece33 · Cited by 172
An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women
Balkus, J. E., Brown, E., Palanee, T., Nair, G., Gafoor, Z., Zhang, J., Richardson, B. A., Chirenje, Z. M., Marrazzo, J. M., & Baeten, J. M. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000974 · Cited by 161
Liu, A. Y., Vittinghoff, E., Sellmeyer, D. E., Irvin, R., Mulligan, K., Mayer, K., Thompson, M., Grant, R., Pathak, S., O'Hara, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023688 · Cited by 160
Mulligan, K. M., Glidden, D. V., Anderson, P. L., Liu, A., McMahan, V., Gonzáles, P., Ramirez-Cardich, M. E., Namwongprom, S., Chodacki, P., de Mendonca, L. M. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ324 · Cited by 159
Challenges in Systematic Reviews That Assess Treatment Harms
Chou, R., & Helfand, M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_2-200506211-00009 · Cited by 159
Self-citationMurnane, P. M., Celum, C., Mugo, N., Campbell, J. D., Donnell, D. J., Bukusi, E. A., Mujugira, A., Tappero, J. W., Kahle, E., Thomas, K. K., et al. (2013) · AIDS · doi:10.1097/qad.0b013e3283629037 · Cited by 158
Mutua, G. N., Sanders, E. J., Mugo, P. M., Anzala, O. A., Haberer, J. E., Bangsberg, D. R., Barin, B., Rooney, J. F., Mark, D., Chetty, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033103 · Cited by 158
Solomon, M. M., Lama, J. R., Glidden, D. V., Mulligan, K. M., McMahan, V., Liu, A., Guanira, J. V., Veloso, V. G., Mayer, K. H., Chariyalertsak, S., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000156 · Cited by 140
Mugo, N., Hong, T., Celum, C., Donnell, D. J., Bukusi, E. A., John-Stewart, G. C., Wangisi, J., Were, E. O., Heffron, R. A., Matthews, L. T., et al. (2014) · JAMA · doi:10.1001/jama.2014.8735 · Cited by 140
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals
Okwundu, C. I., & Okoromah, C. A. N. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007189.pub2 · Cited by 133
Kahle, E., Hughes, J. P., Lingappa, J. R., John-Stewart, G. C., Celum, C., Joloba, M. L., Njuguna, S., Mugo, N., Bukusi, E. A., Manongi, R. N., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31827e622d · Cited by 132
Bekker, L., Roux, S., Sebastien, E., Yola, N., Amico, K. R., Hughes, J. P., Marzinke, M. A., Hendrix, C. W., Anderson, P. L., Elharrar, V., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30156-x · Cited by 125
(2016) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2016.06.028 · Cited by 123
U.S. Preventive Services Task Force (USPSTF)
Martins, C. (2005) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v21i1.10115 · Cited by 120
Hoenigl, M., Weibel, N., Mehta, S. R., Anderson, C. M., Jenks, J. D., Green, N., Gianella, S., Smith, D. M., & Little, S. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ335 · Cited by 112
Martin, M., Vanichseni, S., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Curlin, M. E., Na-pompet, S., Warapronmongkholkul, A., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000613 · Cited by 107
Lehman, D. A., Baeten, J. M., McCoy, C. O., Weis, J. F., Peterson, D. E., Mbara, G., Donnell, D. J., Thomas, K. K., Hendrix, C. W., Marzinke, M. A., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu677 · Cited by 104
Mugwanya, K. K., Wyatt, C. M., Celum, C., Donnell, D. J., Mugo, N., Tappero, J. W., Kiarie, J. N., Ronald, A., & Baeten, J. M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6786 · Cited by 103
Pintye, J. C., Drake, A. L., Kinuthia, J., Unger, J. B., Matemo, D. N., Heffron, R. A., Barnabas, R. V., Kohler, P. K., McClelland, R. S., & John-Stewart, G. C. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw850 · Cited by 100
Jiang, J., Yang, X., Ye, L., Zhou, B., Ning, C., Huang, J., Liang, B., Zhong, X., Huang, A., Tao, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087674 · Cited by 92
Agot, K. E., Taylor, D. J., Corneli, A. L., Wang, M., Ambia, J., Kashuba, A. D. M., Parker, C., Lemons, A., Malahleha, M., Lombaard, J. J., et al. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0859-z · Cited by 87
Kibengo, F., Ruzagira, E., Katende, D., Naggirinya, A. B., Bahemuka, U. M., Haberer, J. E., Bangsberg, D. R., Barin, B., Rooney, J. F., Mark, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074314 · Cited by 86
Lancki, N., Almirol, E. A., Alon, L., McNulty, M., & Schneider, J. A. (2017) · AIDS · doi:10.1097/qad.0000000000001710 · Cited by 86
Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting
Montgomery, M. C., Oldenburg, C. E., Nunn, A. S., Mena, L. A., Anderson, P. L., Liegler, T. J., Mayer, K. H., Patel, R. R., Almonte, A. A., & Chan, P. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157742 · Cited by 82
Liu, A., Glidden, D. V., Anderson, P. L., Amico, K. R., McMahan, V., Mehrotra, M., Lama, J. R., MacRae, J. D., Hinojosa, J., Montoya, O., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000351 · Cited by 78
Landovitz, R. J., Beymer, M. R., Kofron, R., Amico, K. R., Psaros, C., Bushman, L. R., Anderson, P. L., Flynn, R. P., Lee, D. P., Bolan, R., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001538 · Cited by 78
Grant, R. M., Mannheimer, S., Hughes, J. P., Hirsch‐Moverman, Y., Loquere, A., Chitwarakorn, A., Curlin, M. E., Li, M., Amico, K. R., Hendrix, C. W., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1086 · Cited by 62
Celum, C., Morrow, R. A., Donnell, D., Hong, T., Hendrix, C. W., Thomas, K. K., Fife, K. H., Nakku-Joloba, E., Mujugira, A., Baeten, J. M., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2471 · Cited by 61
Renal Function of Participants in the Bangkok Tenofovir Study--Thailand, 2005-2012
Martin, M., Vanichseni, S., Suntharasamai, P., Sangkum, U., Mock, P. A., Gvetadze, R. J., Curlin, M. E., Leethochawalit, M., Chiamwongpaet, S., Cherdtrakulkiat, T., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu355 · Cited by 54
Mirembe, B. G., Kelly, C. W., Mgodi, N. M., Greenspan, S. L., Dai, J. Y., Mayo, A., Piper, J. M., Akello, C. A., Kiweewa, F. M., Magure, T. M., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000858 · Cited by 53
Gulick, R. M., Wilkin, T. J., Chen, Y. Q., Landovitz, R. J., Amico, K. R., Young, A., Richardson, P., Marzinke, M. A., Hendrix, C. W., Eshleman, S. H., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw525 · Cited by 52
Heffron, R. A., Mugo, N., Were, E. O., Kiarie, J. N., Bukusi, E. A., Mujugira, A., Frenkel, L. M., Donnell, D. J., Ronald, A., Celum, C., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000493 · Cited by 47
Beymer, M. R., Weiss, R. E., Sugar, C. A., Bourque, L. B., Gee, G. C., Morisky, D. E., Shu, S. B., Javanbakht, M., & Bolan, R. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000535 · Cited by 47
Jones, J. S., Hoenigl, M., Siegler, A. J., Sullivan, P. S., Little, S. J., & Rosenberg, E. S. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000596 · Cited by 43
Smith, D. K., Pan, Y., Rose, C. E., Pals, S. L., Mehta, S. H., Kirk, G. D., & Herbst, J. H. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000123 · Cited by 41
Matthews, L. T., Heffron, R. A., Mugo, N., Cohen, C. R., Hendrix, C. W., Celum, C., Bangsberg, D. R., & Baeten, J. M. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000246 · Cited by 39
Marcus, J. L., Glidden, D. V., McMahan, V., Lama, J. R., Mayer, K. H., Liu, A., Montoya, O., Casapía, M., Hoagland, B., & Grant, R. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091513 · Cited by 32
Gulick, R. M., Wilkin, T. J., Chen, Y. Q., Landovitz, R. J., Amico, K. R., Young, A., Richardson, P., Marzinke, M. A., Hendrix, C. W., Eshleman, S. H., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0520 · Cited by 32
Murnane, P. M., Brown, E. R., Donnell, D. J., Coley, R. Y., Mugo, N., Mujugira, A., Celum, C., & Baeten, J. M. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv202 · Cited by 30
Massud, I., Mitchell, J. M., Babusis, D. M., Deyounks, F., Ray, A. S., Rooney, J. F., Heneine, W., Miller, M. D., & Garcia-Lerma, J. G. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw312 · Cited by 29
Mandala, J., Nanda, K., Wang, M., Baetselier, I. D., Deese, J., Lombaard, J. J., Owino, F., Malahleha, M., Manongi, R. N., Taylor, D. J., et al. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-77 · Cited by 21
Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected men
Were, E. O., Heffron, R. A., Mugo, N., Celum, C., Mujugira, A., Bukusi, E. A., & Baeten, J. M. (2014) · AIDS · doi:10.1097/qad.0000000000000313 · Cited by 21
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Mayer, K. H., Molina, J.-M., Thompson, M. A., Anderson, P. L., Mounzer, K. C., De Wet, J. J., DeJesus, E., Jessen, H., Grant, R. M., Ruane, P. J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31065-5 · Cited by 428
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Curry, S. J., Doubeni, C. A., Epling, J. W., et al. (2019) · JAMA · doi:10.1001/jama.2019.6390 · Cited by 312
Metadata
- Authors
- Chou, R., Evans, C., Hoverman, A., Sun, C., Dana, T., Bougatsos, C., Grusing, S., & Korthuis, P. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2019-06-11
- Volume
- 321
- Issue
- 22
- Pages
- 2214
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2952934241
- Cited by
- 266
- References
- 70
- FWCI
- 22.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.